Top cited articles
Acceptance rate:
9%
Time to first decision with review:
42 days*
Time from acceptance to publication:
22 days*
Impact Factor(JCR):
8.7
Citescore:
15.7
Total content views:
2.21 million
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy
Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial hypotension
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis
Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis
Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study
Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases
Neuropathology and emerging biomarkers in corticobasal syndrome
Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease
Frailty, lifestyle, genetics and dementia risk
Application of the 2021 EAN/PNS criteria for chronic inflammatory demyelinating polyneuropathy
Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease
Somatic symptom disorder in patients with post-COVID-19 neurological symptoms: a preliminary report from the somatic study (Somatic Symptom Disorder Triggered by COVID-19)
Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion
Association of obesity with disease outcome in multiple sclerosis
Neurodegenerative disease risk among former international rugby union players
Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study